| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.484 | 2.790 | 2.025 | - | 1.100 | 0 | 0 | 1.987 | 435 | 0 |
| Total Income - EUR | 2.484 | 2.790 | 2.025 | - | 1.100 | 0 | 0 | 1.987 | 435 | 0 |
| Total Expenses - EUR | 1.515 | 1.571 | 1.824 | - | 1.176 | 801 | 199 | 1.506 | 465 | 0 |
| Gross Profit/Loss - EUR | 969 | 1.219 | 201 | - | -76 | -801 | -199 | 481 | -31 | 0 |
| Net Profit/Loss - EUR | 894 | 1.135 | 140 | - | -110 | -801 | -199 | 432 | -31 | 0 |
| Employees | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Dr. Popa Catalin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 0 | 155 | 19 | - | 880 | 864 | 17 | 23 | 246 | 246 |
| Inventories | 0 | 19 | 19 | - | 18 | 18 | 17 | 17 | 17 | 17 |
| Receivables | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 136 | 0 | - | 862 | 846 | 0 | 6 | 229 | 229 |
| Shareholders Funds | -5.697 | -4.503 | -4.287 | - | -4.237 | -5.977 | -5.459 | -4.844 | -4.860 | -4.833 |
| Social Capital | 45 | 45 | 44 | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.697 | 4.658 | 4.306 | - | 5.117 | 6.840 | 5.476 | 4.867 | 5.106 | 5.079 |
| Income in Advance | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8513 - 8513" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Popa Catalin S.r.l.